-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to guide and standardize clinical trials of human fibrinogen, the Center for Drug Evaluation initiated the formulation of the "Technical Guidelines for Human Fibrinogen Clinical Trials" in 2021
We now solicit public opinions from the public
Please send your feedback to the mailbox of the following contact:
Contact: Yu Aiping, Wang Yanlin
Contact: yuap@cde.
Thank you for your participation and great support
Drug Evaluation Center of the State Drug Administration
July 22, 2021
Attachment 1: "Technical Guidelines for Clinical Trials of Human Fibrinogen (Draft for Comment)".
Attachment 1: "Technical Guidelines for Clinical Trials of Human Fibrinogen (Draft for Comment)".
Attachment 2: Feedback form for soliciting opinions.
docx